Predictors of Smell Recovery Identified in COVID-19 Patients
About four of every five patients with COVID-19-related olfactory loss report smell recovery within six months.
COVID19
Merck Asks FDA to Approve First COVID-19 Antiviral Pill
Merck & Co. announced that it had submitted an application with the FDA for emergency use approval of the first antiviral pill targeted to COVID-19.
Ciclesonide May Be Promising Outpatient Therapy for Early COVID-19
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
US to Buy $1 Billion Worth of Rapid COVID-19 Tests
The Biden administration said Wednesday that it plans to purchase $1 billion worth of rapid, at-home COVID-19 tests and take other actions to quadruple the number of tests available to Americans by December.
Routine Childhood Vaccination Rates Down During the Pandemic
As of September 2020, childhood vaccination rates were lower than 2019 levels.
Los Angeles Passes Country’s Strictest Vaccine Mandate
One of the strictest COVID-19 vaccine mandates in the United States has been approved in Los Angeles.
Vaccine Effectiveness High for Preventing COVID-19 Hospitalization
Vaccine effectiveness is high for preventing COVID-19-associated hospitalization, even during predominance of the SARS-CoV-2 delta strain.
One-Third of Individuals Have Symptoms 2 Months After SARS-CoV-2
One-third of individuals report having at least one symptom two months after having a positive test result for SARS-CoV-2.
Health Care-Associated Infection Up During COVID-19 Pandemic
In 2020, there were increases in the incidence of health care-associated infection.
Remdesivir Cuts Risk of Hospitalization in COVID-19 Patients at Risk for Disease Progression
The trial included 584 nonhospitalized patients diagnosed with COVID-19 who were considered at high risk for disease progression based on comorbidities and age.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...